Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapy-Reference-Cited by-同舟云学术

Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapy

Published:2002-01 Issue:1 Volume:3 Page:12-20
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Weiss L,Burgard M,Cahen YD,Chaix ML,Laureillard D,Gilquin J,Piketty C,Viard JP,Kazatchkine MD,Girard PM,Rouzioux C

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference28 articles.

1. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

2. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

3. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

4. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)

5. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients;BMC Infectious Diseases;2012-01-20

2. Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends;Gastrointestinal Endoscopy;2010-02

3. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals;AIDS;2008-11-12

4. Successful Treatment with Atazanavir and Lopinavir/Ritonavir Combination Therapy in Protease Inhibitor-Susceptible and Protease Inhibitor-Resistant HIV-Infected Patients;AIDS Patient Care and STDs;2006-11

5. An Immunological Comparison of Third Companion in Advanced Drug-Naive HIV-Infected Patients;HIV Clinical Trials;2006-10